Literature DB >> 22242740

Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai, China.

Jiang Du1, Zhen Wang, Bin Xie, Min Zhao.   

Abstract

OBJECTIVE: The aim was to investigate hepatitis C virus (HCV) knowledge and alcohol consumption among patients (n = 114) in a methadone maintenance treatment (MMT) clinic in Shanghai.
METHODS: A cross-sectional survey was carried out in an MMT clinic. Structured questionnaires (HCV Knowledge Scale and Alcohol Use Disorders Identification Test (AUDIT)) and some open-ended questions were used to assess (i) HCV knowledge, (ii) HCV treatment received, (iii) awareness of HCV status, and (iv) alcohol consumption.
RESULTS: Findings revealed the HCV-positive rate was 57.0%. There were significant gaps in knowledge about HCV and HCV treatment received. The group mean score of HCV knowledge was 11.3 out of 20 (SD = 2.1) and the mean score on the AUDIT was 3.2 (SD = 5.4). Most participants (68.4%) reported not knowing their HCV status. Among HCV-positive participants, only 15.3% had received HCV antivirus treatment and 18.4% expressed a need for counseling about HCV infection.
CONCLUSIONS: Considering the limited HCV knowledge and low level of HCV treatment received, effective HCV education and intervention strategies should be developed to target patients in China's MMT clinics. Moreover, alcohol screening should also be part of the routine assessments within MMT programs. SCIENTIFIC SIGNIFICANCE: This study reveals the importance of HCV testing and education among drug users in MMT clinics.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22242740      PMCID: PMC3437407          DOI: 10.3109/00952990.2011.643974

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  10 in total

Review 1.  The effect of methadone maintenance treatment on alcohol consumption: a systematic review.

Authors:  Anita Srivastava; Meldon Kahan; Sue Ross
Journal:  J Subst Abuse Treat       Date:  2007-06-27

2.  Injecting drug users' understanding of hepatitis C.

Authors:  Susannah O'Brien; Carolyn Day; Emma Black; Kate Dolan
Journal:  Addict Behav       Date:  2008-07-22       Impact factor: 3.913

3.  Integrating primary medical care with addiction treatment: a randomized controlled trial.

Authors:  C Weisner; J Mertens; S Parthasarathy; C Moore; Y Lu
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

4.  Hepatitis C knowledge among staff in U.S. drug treatment programs.

Authors:  Shiela M Strauss; Janetta M Astone-Twerell; Corrine Munoz-Plaza; Don C Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Journal:  J Drug Educ       Date:  2006

5.  Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs.

Authors:  C Laine; W W Hauck; M N Gourevitch; J Rothman; A Cohen; B J Turner
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

Review 6.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

Review 7.  Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.

Authors:  Xian Xia; Jun Luo; Jianling Bai; Rongbin Yu
Journal:  Public Health       Date:  2008-05-19       Impact factor: 2.427

8.  An epidemiological survey of alcohol use disorders in a Tibetan population.

Authors:  Wanjun Guo; Gongga Lanzi; Ouzhu Luobu; Xiaohong Ma; Puo Zhen; Yulin Ji; Geng Wei; Zheng Wang; Wei Deng; Basang Zhuoma; Yingcheng Wang; Xiaoming Shi; Chengyin Yan; Xiehe Liu; David A Collier; David Ball; Tao Li
Journal:  Psychiatry Res       Date:  2008-04-21       Impact factor: 3.222

9.  Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.

Authors:  J Chetwynd; C Brunton; M Blank; E Plumridge; D Baldwin
Journal:  N Z Med J       Date:  1995-09-08

10.  Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services.

Authors:  Shiela M Strauss; Janetta Astone-Twerell; Corrine E Munoz-Plaza; Don C Des Jarlais; Marya Gwadz; Holly Hagan; Andrew Osborne; Andrew Rosenblum
Journal:  BMC Health Serv Res       Date:  2007-03-08       Impact factor: 2.655

  10 in total
  14 in total

1.  Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers.

Authors:  Kelly E Dunn; Kathryn A Saulsgiver; Mollie E Patrick; Sarah H Heil; Stephen T Higgins; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2013-08-30       Impact factor: 4.492

2.  A comparative study of patients' knowledge about hepatitis C in the United States and in urban and rural China.

Authors:  Elizabeth Wu; Xisui Chen; Zhe Guan; Claudia Cao; Huiying Rao; Bo Feng; Melvin Chan; Sherry Fu; Andy Lin; Lai Wei; Anna S Lok
Journal:  Hepatol Int       Date:  2014-07-31       Impact factor: 6.047

Review 3.  The globalization of addiction research: capacity-building mechanisms and selected examples.

Authors:  Richard A Rawson; George Woody; Thomas F Kresina; Steven Gust
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

Review 4.  A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan.

Authors:  Heather Bennett; Nathalie Waser; Karissa Johnston; Jia-Horng Kao; Young-Suk Lim; Zhong-Ping Duan; Youn-Jae Lee; Lai Wei; Chien-Jen Chen; William Sievert; Yong Yuan; Hong Li
Journal:  Hepatol Int       Date:  2015-06-13       Impact factor: 6.047

5.  HIV, Hepatitis C, and Abstinence from Alcohol Among Injection and Non-injection Drug Users.

Authors:  Jennifer C Elliott; Deborah S Hasin; Malka Stohl; Don C Des Jarlais
Journal:  AIDS Behav       Date:  2016-03

6.  Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.

Authors:  Jan Klimas; Christopher Fairgrieve; Helen Tobin; Catherine-Anne Field; Clodagh Sm O'Gorman; Liam G Glynn; Eamon Keenan; Jean Saunders; Gerard Bury; Colum Dunne; Walter Cullen
Journal:  Cochrane Database Syst Rev       Date:  2018-12-05

7.  Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study.

Authors:  Xia Zou; Li Ling; Lei Zhang
Journal:  BMJ Open       Date:  2015-08-21       Impact factor: 2.692

8.  Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program.

Authors:  Changhe Wang; Cynthia X Shi; Keming Rou; Yan Zhao; Xiaobin Cao; Wei Luo; Enwu Liu; Zunyou Wu
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

9.  Hepatitis C infection, related services, and barriers to HCV treatment among drug users in methadone maintenance treatment (MMT) clinics in Shanghai, China.

Authors:  Zhi-Bin Li; Lei Zhang; Jun Wang; Le-Ping Huang; Zhi-Rong Zhou; Yi-Ning Cao; Min Zhao; Jiang Du
Journal:  Harm Reduct J       Date:  2017-11-02

10.  HIV and hepatitis C virus testing delays at methadone clinics in Guangdong Province, China.

Authors:  Ying-Hua Xia; Megan M McLaughlin; Wen Chen; Li Ling; Joseph D Tucker
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.